TG Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 193.1 | 53.9 | 29.7 | – | 206.3 | 163.8 | 96.8 | 13.0 | 10.6 | 11.5 | 19.6 | |
| 2,486.3 | 1,519.9 | 4,081.5 | 4,194.8 | 5,082.3 | 3,582.4 | 6,586.6 | 6,267.0 | 2,880.0 | 2,189.6 | 4,272.3 | 4,968.2 | 3,303.6 | 6,985.7 | 6,799.5 | 14,413.8 | 21,012.7 | 42,453.9 | 7,009.4 | 2,122.8 | 1,000.3 | 376.5 | 161.4 | 85.1 | 158.9 | 581.1 | 245.6 | 145.9 | 6.9 | 10.5 | 7.7 | 8.2 | 14.2 | 14.7 | 16.6 | 12.9 | 10.9 | 7.7 | 7.6 | 10.8 | |
| 6.7 | 6.5 | 6.2 | 8.2 | 9.7 | 8.1 | 11.8 | 9.4 | 6.1 | 13.8 | 33.7 | 57.2 | – | 27.5 | – | 11.3 | 18.7 | 12.4 | 14.3 | 13.4 | 14.1 | 10.6 | 7.5 | 4.6 | 7.9 | 27.6 | – | – | 7.9 | 15.2 | 13.9 | 16.0 | 19.6 | 21.7 | 27.0 | 21.2 | 9.6 | 7.3 | 9.1 | 14.3 | |
| 2,295.7 | 1,356.1 | 3,455.0 | 3,552.3 | 4,480.8 | 3,211.1 | 6,043.7 | 5,574.1 | 2,415.7 | 1,659.8 | 4,044.2 | 4,569.2 | 2,978.8 | 6,445.9 | 6,659.7 | 12,904.4 | 19,546.4 | 39,020.6 | 6,524.4 | 1,966.6 | 930.2 | 342.2 | 146.6 | 74.1 | 151.3 | 570.5 | 249.8 | 146.0 | 6.6 | 10.5 | 7.8 | 8.2 | 14.4 | 14.9 | 16.9 | 13.1 | 11.3 | 8.0 | 8.0 | 11.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 94.1 | 41.6 | 26.3 | 640.1 | 97.7 | 92.4 | 61.1 | 51.9 | 36.6 | 37.4 | 66.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 109.6 | 41.8 | – | – | – | – | – | – | – | – | |
| -15.2% | -26.7% | -10.8% | -12.7% | -11.5% | -17.2% | -9.9% | -11.2% | -26.7% | -38.8% | -20.7% | -18.0% | -27.1% | -12.5% | -15.7% | -7.7% | -6.0% | -3.3% | -3.7% | -4.9% | -5.9% | -11.8% | -22.2% | -45.9% | -30.0% | -10.9% | -8.0% | -4.6% | -3.2% | -1.3% | 0.9% | 2.4% | -0.7% | -0.8% | -1.0% | -1.0% | -1.2% | -0.5% | -0.3% | 0.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | -51,823,374.1% | -51,823,374.1% | -51,823,374.1% | -51,823,374.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -111,120.4% | -111,120.4% | -111,120.4% | -111,120.4% | 30.3% | 73.0% | 83.7% | 84.5% | 88.2% | 88.8% | 89.1% | 90.6% | 90.5% | 89.7% | 88.5% | 96.7% | 93.9% | 93.5% | 92.7% | 88.2% | 88.3% | 87.4% | 87.0% | 85.3% | 83.6% | 83.0% | 82.4% | |
| -47,631.3% | -51,823.5% | -60,797.2% | -68,936.0% | -73,306.4% | -77,904.6% | -87,087.7% | -97,602.3% | -99,467.3% | -114,736.8% | -110,205.3% | -104,415.1% | -121,871.1% | -111,219.7% | -121,453.9% | -131,520.4% | -147,876.3% | -179,996.1% | -34,459.9% | -14,051.3% | -7,685.1% | -5,154.3% | -4,075.3% | -4,078.3% | -4,651.2% | -6,926.7% | -1,901.3% | -701.4% | -10.0% | 8.8% | 16.7% | 29.4% | -0.2% | 12.7% | 15.5% | 18.9% | 19.3% | 20.0% | 21.3% | 17.1% | |
| -47,375.0% | -51,353.4% | -60,461.4% | -68,634.4% | -73,034.3% | -77,749.9% | -86,861.2% | -97,289.9% | -98,939.3% | -114,132.9% | -109,940.1% | -104,723.7% | -123,130.9% | -113,730.3% | -124,230.3% | -135,198.0% | -151,798.7% | -183,803.3% | -35,159.1% | -14,271.2% | -7,784.4% | -5,204.1% | -4,126.5% | -4,144.5% | -4,749.8% | -7,124.1% | -1,966.6% | -730.3% | -13.7% | 5.4% | 14.2% | 27.6% | -5.4% | 7.1% | 10.1% | 13.3% | 84.1% | 72.6% | 66.0% | 55.2% | |
| -37,913.5% | -40,645.0% | -44,153.7% | -53,310.6% | -58,377.7% | -61,533.6% | -65,357.4% | -70,250.9% | -77,040.1% | -84,878.3% | -88,363.8% | -89,456.6% | -89,609.2% | -87,458.6% | -106,417.8% | -111,681.6% | -127,046.1% | -141,357.9% | -25,810.7% | -10,379.8% | -5,928.9% | -4,425.7% | -3,580.8% | -3,908.6% | -4,762.2% | -6,328.4% | -1,953.0% | -666.4% | -22.2% | -13.4% | 7.0% | 19.6% | -10.6% | -12.3% | -15.8% | -13.0% | -13.2% | -4.1% | -2.0% | -0.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -127.2% | -218.2% | -91.2% | -134.1% | -139.9% | -176.8% | -155.2% | -146.1% | -209.7% | -721.8% | -867.9% | -1,205.5% | – | -447.7% | – | -105.8% | -135.2% | -53.8% | -71.6% | -89.9% | -110.1% | -146.8% | -191.6% | -223.6% | -237.5% | -338.5% | – | – | -15.7% | 7.9% | 25.7% | 53.9% | -7.5% | 10.5% | 16.5% | 21.9% | 73.7% | 69.0% | 79.2% | 73.1% | |
| -95.4% | -142.8% | -74.7% | -103.3% | -109.3% | -121.7% | -109.3% | -105.2% | -131.6% | -207.5% | -142.2% | -149.3% | -200.5% | -106.0% | -185.4% | -69.8% | -84.3% | -44.7% | -58.1% | -71.6% | -83.7% | -91.7% | -107.7% | -114.6% | -109.5% | -102.5% | -85.4% | -79.5% | -7.8% | 3.8% | 11.0% | 23.8% | -2.5% | 4.0% | 6.0% | 8.6% | 43.7% | 42.1% | 30.2% | 26.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -29 | -25 | -95 | -98 | -92 | -57 | -83 | -105 | -71 | -81 | -35 | -61 | -49 | -82 | -21 | -229 | -223 | -522 | -440 | -377 | -309 | -230 | -117 | -77 | -38 | -30 | 37 | 2.2 | -51 | 8.6 | 27 | 21 | 50 | 66 | 114 | 117 | 173 | 168 | 305 | 265 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 0.5 | 0.2 | 8.3 | 1.3 | 1.6 | 1.2 | 1.5 | 1.2 | 2.0 | 2.0 | |
| 75.0% | 65.5% | 82.0% | 77.1% | 78.2% | 68.8% | 70.4% | 72.0% | 62.7% | 28.7% | 16.4% | 12.4% | -709.0% | 23.7% | -1.3% | 65.9% | 62.3% | 83.0% | 81.2% | 79.6% | 76.0% | 62.5% | 56.2% | 51.3% | 46.1% | 30.3% | -793.6% | -730.7% | 49.8% | 48.7% | 42.9% | 44.3% | 32.8% | 38.5% | 36.1% | 39.3% | 59.2% | 60.9% | 38.1% | 36.8% | |
| 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 | 1.5 | -0.3 | – | 0.8 | – | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.5 | 0.7 | 1.2 | – | – | 0.6 | 0.6 | 0.6 | 0.6 | 1.3 | 1.1 | 1.0 | 0.9 | 0.4 | 0.4 | 1.3 | 1.2 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.47 | -1.59 | -1.73 | -1.65 | -1.71 | -1.78 | -1.87 | -2.05 | -1.92 | -2.14 | -2.06 | -1.83 | -2.09 | -1.81 | -1.79 | -1.83 | -1.94 | -2.25 | -2.42 | -2.61 | -2.59 | -2.63 | -2.43 | -2.09 | -1.76 | -1.45 | -1.20 | -1.24 | -0.17 | 0.09 | 0.28 | 0.60 | -0.09 | 0.15 | 0.24 | 0.37 | 2.78 | 2.81 | 2.89 | 2.81 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | 0.05 | 0.04 | 0.02 | 0.06 | 0.17 | 1.22 | 1.63 | 1.98 | 2.17 | 1.65 | 2.05 | 2.37 | 2.79 | 3.30 | 3.87 | 4.38 | 5.08 | |
| 1.15 | 0.73 | 1.90 | 1.23 | 1.22 | 1.01 | 1.21 | 1.40 | 0.92 | 0.30 | 0.24 | 0.15 | -7.38 | 0.40 | -0.01 | 1.73 | 1.43 | 4.19 | 3.38 | 2.90 | 2.35 | 1.79 | 1.27 | 0.94 | 0.74 | 0.43 | -11.16 | -11.41 | 1.06 | 1.12 | 1.10 | 1.11 | 1.20 | 1.39 | 1.46 | 1.70 | 3.77 | 4.07 | 3.64 | 3.84 | |
| -1.17 | -1.26 | -1.27 | -1.28 | -1.37 | -1.41 | -1.41 | -1.48 | -1.50 | -1.59 | -1.65 | -1.57 | -1.52 | -1.39 | -1.53 | -1.51 | -1.62 | -1.73 | -1.77 | -1.90 | -1.97 | -2.23 | -2.11 | -1.97 | -1.77 | -1.28 | -1.19 | -1.13 | -0.27 | -0.22 | 0.14 | 0.43 | -0.17 | -0.25 | -0.38 | -0.36 | -0.44 | -0.16 | -0.09 | 0.00 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.